Curis (CRIS) Cash & Equivalents Growth (1y) (2011 - 2026)
Curis (CRIS) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Curis |
8.27 Mn |
-6.73 Mn |
- |
-26.04% |
| Date | Value |
|---|
| Mar 31, 2026 |
-26.04% |
| Dec 31, 2025 |
-74.69% |
| Sep 30, 2025 |
-56.60% |
| Jun 30, 2025 |
1.42% |
| Mar 31, 2025 |
-32.29% |
| Dec 31, 2024 |
-25.05% |
| Sep 30, 2024 |
-14.77% |
| Jun 30, 2024 |
-49.57% |
| Mar 31, 2024 |
-5.49% |
| Dec 31, 2023 |
35.73% |
| Sep 30, 2023 |
-18.03% |
| Jun 30, 2023 |
-41.71% |
| Mar 31, 2023 |
71.63% |
| Dec 31, 2022 |
-50.87% |
| Sep 30, 2022 |
-43.70% |
| Jun 30, 2022 |
-54.67% |
| Mar 31, 2022 |
-83.37% |
| Dec 31, 2021 |
-69.13% |
| Sep 30, 2021 |
124.66% |
| Jun 30, 2021 |
217.62% |
